Technology News and Research

RSS

New biodegradable membrane reduces wound healing time by 50%

Treatments to regenerate skin from burns become tedious and long lasting; however, Mexican researchers developed a biodegradable membrane that allows to transfer skin cells (keratinocytes) to burn wounds, when placed on the wound. The method reduces healing time by 50 percent.

3 Apr 2015

Pyrexar Medical procures hyperthermia assets of BSD Medical, begins operations

Pyrexar Medical begins operations today after completing the acquisition of hyperthermia assets held by Perseon, formerly BSD Medical. This acquisition includes substantially all hyperthermia assets, products, services and related intellectual property.

3 Apr 2015

Novel biosensing platform could remotely determine treatment options for HIV, E-coli

In much the same way that glucometers and pregnancy tests have revolutionized in-home diagnostic testing, researchers from Florida Atlantic University and collaborators have identified a new biosensing platform that could be used to remotely detect and determine treatment options for HIV, E-coli, Staphylococcus aureas and other bacteria.

3 Apr 2015

Elsevier invites submission for its new open-access journal, Heliyon

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced the call for submissions for its new open access journal Heliyon.

3 Apr 2015

Analytical innovations top $10M in licensing income for PNNL, Battelle

A suite of analytical innovations used to detect and measure very low levels of compounds and elements for environmental, national security and health applications has topped $10 million in licensing income for Pacific Northwest National Laboratory and its operator Battelle.

3 Apr 2015

AMGA premieres first segments of in-depth, online program aimed at nation's healthcare industry

Last week at its 2015 Annual Conference, the American Medical Group Association (AMGA) premiered the first segments of an in-depth, online program specifically aimed at the nation's healthcare industry, High-Performing Health.

3 Apr 2015

Researchers test effects of light therapy on brain function

Following up on promising results from pilot work, researchers at the VA Boston Healthcare System are testing the effects of light therapy on brain function in veterans with Gulf War Illness.

3 Apr 2015

SGI-DNA introduces BioXp system to give researchers priority access to personal DNA work station

SGI-DNA Inc. today announced the launch of the BioXp 3200 System Early Access Program giving researchers priority access to this one of a kind, personal DNA work station which delivers high quality synthetic DNA fragments.

2 Apr 2015

Thoratec gets final FDA approval to expand enrollment of HeartMate III U.S. clinical trial

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it received final approval from the FDA to broaden enrollment of the HeartMate III U.S. clinical trial of up to 1,028 patients in up to 60 sites.

2 Apr 2015

Olympus unveils CX23® microscope for education, training and laboratory use

Olympus has unveiled the CX23® microscope, designed to provide high-quality optical performance and stress-free, dependable operation in laboratory, classroom and training facilities worldwide.

From Evident Corporation - Life Sciences 2 Apr 2015

Columbia Laboratories to adopt Juniper Pharmaceuticals brand marks

Columbia Laboratories, Inc., today announced that it will adopt Juniper Pharmaceuticals, Inc. as its new corporate brand. The name change will become effective Friday, April 10, 2015, and the Company's common stock will begin trading on the Nasdaq Stock Exchange under the new ticker symbol — "JNP" — on Monday, April 13, 2015.

2 Apr 2015

Novogen appoints PCG Advisory to manage investor-awareness program in the US

Novogen Ltd today announced it has appointed US-based public relations firm, PCG Advisory (PCG), to drive the Company's investor-awareness program in the US. PCG will be using their expertise in creating awareness and establishing key relationships within the US investment community via their targeted outreach campaign.

2 Apr 2015

BioLight forms strategic partnership with Rock-One to expand its presence within China

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced today an agreement to enter into a strategic partnership with Rock-One International Holdings Ltd., a holding company specializing in investment activities, including in the high tech and biomedical industries.

2 Apr 2015

Penn Med's BLINKER Team named one of 16 finalists in NIH 'Follow that Cell Challenge'

James Eberwine, PhD, the Elmer Holmes Bobst Professor of Systems Pharmacology and Experimental Therapeutics, at the Perelman School of Medicine at the University of Pennsylvania, was named one of 16 finalists in the first phase of the Follow that Cell Challenge funded by the National Institutes of Health. The competition was run by crowdsourcing company Innocentive and 687 designated "solvers" entered initially.

2 Apr 2015

Registration opens for inaugural Stanford Medicine X|ED conference

Registration opened today for the inaugural Stanford Medicine X|ED conference, which will explore the role of technology and networked intelligence in shaping the future of medical education.

2 Apr 2015

Novel molecule inhibits cancer-causing transcription factors

A novel molecule designed by scientists at the University of Massachusetts Medical School and the University of Virginia inhibits progression of a hard-to-treat form of recurring acute myeloid leukemia (AML) in patient tissue.

2 Apr 2015

Scientists uncover the genetic root of prostate cancer

Scientists have revealed the root of prostate cancers in individual men, discovering that despite huge genetic variety between tumours they also share common gene faults - insight that could offer new treatment hopes, according to research published in Nature today (Wednesday).

2 Apr 2015

NIH approves $6.6 million in funding for Phase 2a adult eradication study of Argos' AGS-004

Argos Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on the Arcelis technology platform, today announced that the NIH Division of AIDS (DAIDS) has approved $6.6 million in funding for an investigator-initiated Phase 2a adult eradication study of AGS-004, the company’s investigational fully personalized immunotherapy for HIV.

2 Apr 2015

McGraw-Hill Education introduces ObGyn Collection on AccessMedicine

McGraw-Hill Education, a leading global provider of content and services for the science, technical, and medical communities, announced the launch of the ObGyn Collection on AccessMedicine, the latest addition to the McGraw-Hill Education suite of comprehensive online resources for medical students, residents, and healthcare professionals.

1 Apr 2015

MD Anderson, NanoString Technologies collaborate to accelerate development of 'multi-omic' assays

The University of Texas MD Anderson Cancer Center and NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced a multi-year collaboration to accelerate the development and adoption of a new type of assay based on NanoString's nCounter Analysis System.

From NanoString Technologies 1 Apr 2015

Technology News and Research

New biodegradable membrane reduces wound healing time by 50%

Pyrexar Medical procures hyperthermia assets of BSD Medical, begins operations

Novel biosensing platform could remotely determine treatment options for HIV, E-coli

Elsevier invites submission for its new open-access journal, Heliyon

Analytical innovations top $10M in licensing income for PNNL, Battelle

AMGA premieres first segments of in-depth, online program aimed at nation's healthcare industry

Researchers test effects of light therapy on brain function

SGI-DNA introduces BioXp system to give researchers priority access to personal DNA work station

Thoratec gets final FDA approval to expand enrollment of HeartMate III U.S. clinical trial

Olympus unveils CX23® microscope for education, training and laboratory use

Columbia Laboratories to adopt Juniper Pharmaceuticals brand marks

Novogen appoints PCG Advisory to manage investor-awareness program in the US

BioLight forms strategic partnership with Rock-One to expand its presence within China

Penn Med's BLINKER Team named one of 16 finalists in NIH 'Follow that Cell Challenge'

Registration opens for inaugural Stanford Medicine X|ED conference

Novel molecule inhibits cancer-causing transcription factors

Scientists uncover the genetic root of prostate cancer

NIH approves $6.6 million in funding for Phase 2a adult eradication study of Argos' AGS-004

McGraw-Hill Education introduces ObGyn Collection on AccessMedicine

MD Anderson, NanoString Technologies collaborate to accelerate development of 'multi-omic' assays

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News